01-01-1970 12:00 AM | Source: ICICI Direct
Hold VST Industries Ltd For Target Rs.3850 - ICICI Direct
News By Tags | #872 #3525 #3961 #1302 #1277

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

Volumes recover partly; focus on high priced brands

About the stock VST Industries (VST) is among the oldest cigarette company in India, involved in manufacturing and marketing of cigarettes and also trading unmanufactured tobacco. Incorporated in 1930, it is an associate undertaking of British American Tobacco (BAT), the global leader in cigarettes.

* VST has two cigarettes manufacturing facilities in Hyderabad, AP. It has five major brands, including, ‘Total’, ‘Charms’, ‘Moment’, ‘Special’, and ‘Edition’. It has a direct distribution reach of over 1.1 million retail outlets

 

Q1FY22 Results: VST reported strong cigarette volume recovery in Q1FY22.

* Sales were up 12.1% YoY; cigarette volumes grew 35%

* EBITDA was at | 92 crore, down 7.4% YoY, with margins at 33.4%

* Consequent PAT was at | 70.4 crore (down 7% YoY)

 

What should investors do?

VST Industries’ share price has underperformed the market with 70% return in the last five years (from | 2000 in July 2016 to | 3476 in July 2021). The pandemic has severely impacted the cigarettes industry.

* We roll over FY24 numbers estimating a complete recovery in cigarettes business in FY23-24

* We continue to maintain our HOLD rating on the stock

Target Price and Valuation: We value the stock at | 3850, valuing the business at 15x FY24 earnings

 

Key triggers for future price performance:

* With Covid recovery & vaccination drive, mobility is expected to increase by H2FY22

* High priced brands’ (‘Total’ & ‘Edition’) volume contribution to increase in future, which would lead to favourable product mix & margin improvement

* Duties & taxes on cigarettes are expected to remain stable given increasing prevalence of illicit & contraband cigarettes

* We expect dividend payout to increase to ~70% by FY23, which would translate into dividend yield of ~5% at the current price

 

Alternate Stock Idea: We like Zydus Wellness in our FMCG coverage

* It is growing at a steady pace in nascent categories with a strong presence in health, nutrition space & margin expansion possibilities

Trading at significant discount to FMCG peers. BUY with TP of | 2,800

 

To Read Complete Report & Disclaimer Click Here

 

https://secure.icicidirect.com/Content/StaticData/Disclaimer.html

 

Above views are of the author and not of the website kindly read disclaimer